We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Body Surface Area Helps Predict Response to Blood Transfusion

By LabMedica International staff writers
Posted on 06 Oct 2016
The risks associated with unnecessary transfusion of blood products, including infections, transfusion reactions, and, in some clinical situations, alloimmunization, makes a judicious approach to transfusion is of the utmost importance.

However, despite several decades of experience with red blood cell (RBC) transfusion, the ability to predict transfusion requirements based on the expected rise in hemoglobin (Hgb) has been limited. More...
As a result, decisions regarding RBC transfusion have been based on clinical experience and gestalt.

Medical scientists at the Eastern Virginia Medical School (Norfolk, VA, USA) determined the variability of response to red blood cell transfusion and to predict which patients will have an Hgb rise higher or lower than that predicted by the long-standing convention of “one and three”. The study was a retrospective chart review in a single hospital and data for 167 consecutive patient encounters were reviewed. The dataset was randomly divided into derivation and validation subsets with no significant differences in characteristics. Pre-transfusion Hgb was checked no earlier than 12 hours prior to transfusion, and post-transfusion Hgb checked between three and 24 hours after transfusion.

DeltaHgb was defined as post-transfusion Hgb minus pre-transfusion Hgb per red blood cell unit. They classified all the patients in both the subsets as “high responders” (DeltaHgb greater than 1 g/dL) or as “low responders” (DeltaHgb equal to or less than 1 g/dL). In univariate analysis, age, sex, body weight, estimated blood volume, and body surface area were significantly associated with response category. The mean DeltaHgb per RBC unit in the series was 1.23 g/dL. This lends support to the rule of thumb, which lacks large published datasets to support this rule. Then, multiple different prediction models were tested using a variety of variables.

The authors concluded that the best-performing model used body surface area (BSA) and correctly classified 69% of patients, with a sensitivity of 84.6% and a specificity of 43.8% when tested on an independent dataset without any overlap with the derivation dataset. The study was published on September 21, 2016, in the Journal of Blood Medicine.

Related Links:
Eastern Virginia Medical School


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
Laboratory Software
ArtelWare
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.